Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

SMARCB1-Deficient Sinonasal Carcinoma–A Case Report and Literature Review

Kim T, Hong WG, Cho KJ, Yu MS

Switch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1)-deficient sinonasal carcinoma is a rare subtype of sinonasal undifferentiated carcinoma (SNUC). Due to the highly aggressive nature of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Neonatal Form of Alexander Disease Presented with Intractable Seizures and Obstructive Hydrocephalus

Yoo IH, Hong WG, Kim H, Lim BC, Hwang H, Chae JH, Kim KJ, Hwang YS

Alexander disease is a rare degenerative leukodystrophy caused by dominant mutations in glial fibrillary acidic protein (GFAP). The neonatal form of Alexander disease may manifest as frequent and intractable seizures...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effectiveness and Tolerability of Fosphenytoin for Pediatric Status Epilepticus

Hong WG, Yoo IH, Kim JS, Ryu HW, Byun SH, Kim H, Lim BC, Chae JH, Choi J, Kim KJ, Hwang YS, Hwang H

  • KMID: 2329619
  • J Korean Child Neurol Soc.
  • 2013 Mar;21(1):1-6.
PURPOSE: The study was aimed to investigate the effectiveness and tolerability of intravenous fosphenytoin (fPHT) in the treatment of pediatric status epilepticus (SE). METHODS: Medical-records of patients who received intravenous (IV)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Tolerability of Rufinamide for Intractable Generalized Epilepsies

Yoo IH, Hong WG, Kim JS, Ryu HW, Byun SH, Kim H, Lim BC, Chae JH, Choi J, Kim KJ, Hwang YS, Hwang H

  • KMID: 2059497
  • J Korean Child Neurol Soc.
  • 2012 Sep;20(3):164-169.
PURPOSE: The purpose of the study was to evaluate the efficacy and safety of rufinamide for intractable generalized epilepsies. METHODS: Eighteen patients with intractable generalized epilepsies were included in the study....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr